The bill establishes a special legislative commission on perimenopause and menopause care in the Commonwealth, comprising 19 members from various health and community organizations. The commission is responsible for collecting data on these conditions, assessing the availability of current care, identifying gaps in healthcare services, and evaluating their impact on the workforce. It is required to issue a report by December 31, 2027, with findings and recommendations aimed at improving awareness, access to care, and health outcomes related to perimenopause and menopause.

Additionally, the bill mandates the Department of Public Health to create and disseminate information on perimenopause and menopause in multiple languages and requires coverage for hormonal and non-hormonal therapies for state employees and Medicaid recipients without restrictive utilization controls. It introduces continuing education requirements for healthcare providers regarding the diagnosis and treatment of these conditions and amends anti-discrimination laws to include protections related to perimenopause and menopause in the workplace. The bill also prohibits employers from requiring unnecessary accommodations or leave when reasonable alternatives exist and mandates a good faith interactive process for determining effective accommodations. Furthermore, it expands health insurance coverage for therapies related to perimenopause and menopause, ensuring that such treatments follow established clinical guidelines without imposing stricter utilization controls than those for other medications.

Statutes affected:
Bill Text: 112-2